期刊
TUMOR BIOLOGY
卷 39, 期 5, 页码 -出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/1010428317691688
关键词
Prostate-derived Ets factor; Sam-pointed domain containing Ets transcription factor; oncogenic driver in breast cancer; biomarker in breast cancer
类别
资金
- National Cancer Institute (NCI) [R41 CA84167]
- Roswell Park Alliance Foundation
- NCI grant [P30CA016056]
Prostate-derived Ets factor (PDEF), a member of the Ets family of transcription factors, differs from other family members in its restricted expression in normal tissues and its unique DNA-binding motif. These interesting attributes coupled with its aberrant expression in cancer have rendered PDEF a focus of increasing interest by tumor biologists. This review provides a current understanding of the characteristics of PDEF expression and its role in breast cancer. The bulk of the evidence is consistent with PDEF overexpression in most breast tumors and an oncogenic role for this transcription factor in breast cancer. In addition, high PDEF expression in estrogen receptor-positive breast tumors showed significant correlation with poor overall survival in several independent cohorts of breast cancer patients. Together, these findings demonstrate PDEF to be an oncogenic driver of breast cancer and a biomarker of poor prognosis in this cancer. Based on this understanding and the limited expression of PDEF in normal human tissues, the development of PDEF-based therapeutics for prevention and treatment of breast cancer is also discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据